Search Results - "immunogenicity"

Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study by Brandon J. Essink, Craig Shapiro, Marie Grace Dawn Isidro, Paul Bradley, Antoinette Pragalos, Mark Bloch, Joel Santiaguel, Melchor Victor Frias, Spiros Miyakis, Margarida Alves de Mesquita, Stefano Berrè, Charlotte Servais, Natasha Waugh, Claudia Hoffmann, Emna Baba, Oliver Schönborn-Kellenberger, Olaf-Oliver Wolz, Sven D. Koch, Tapiwa Ganyani, Philippe Boutet, Philipp Mann, Stefan O. Mueller, Roshan Ramanathan, Martin Robert Gaudinski, Nicolas Vanhoutte

Connect to this object online.

Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study by Nan-Chang Chiu, Li-Min Huang, Arnold Willemsen, Chiranjiwi Bhusal, Ashwani Kumar Arora, Zenaida Reynoso Mojares, Daniela Toneatto

Connect to this object online.

Novel H7N9 influenza immunogen design enhances mobilization of seasonal influenza T cell memory in H3N2 pre-immune mice by Leonard Moise, Lauren M. Meyers, Hyesun Jang, Mayara Grizotte-Lake, Christine M. Boyle, Bethany McGonnigal, Pan Ge, Ted M. Ross, Anne S. De Groot

Connect to this object online.

Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study by Gadey Sampath, Angelika Banzhoff, Alaka Deshpande, Claudius Malerczyk, Ashwani Kumar Arora, Hoshang Vakil, Scott Preiss

Connect to this object online.

Oral Immunogenicity of Enterotoxigenic <i>Escherichia coli</i> Outer Membrane Vesicles Encapsulated into Zein Nanoparticles Coated with a Gantrez^® AN-Mannosamine Polymer Conjugate by Melibea Berzosa, Alzbeta Nemeskalova, Alba Calvo, Gemma Quincoces, María Collantes, Felix Pareja, Carlos Gamazo, Juan Manuel Irache

Connect to this object online.

Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in HIV-infected adults in the era of highly active antiretroviral therapy: analysis stratified by CD4 T-cell count by Joon Young Song, Hee Jin Cheong, Ji Yun Noh, Min Joo Choi, Jin Gu Yoon, Woo Joo Kim

Connect to this object online.

Immunogenicity and safety of tixagevimab-cilgavimab for COVID-19 pre-exposure prophylaxis in immunocompromised 20 to <40 kg children and adolescents: A pilot, prospective, open-labeled study by Jassada Buaboonnam, Supattra Rungmaitree, Nuntawan Piyaphanee, Sirirat Charuvanij, Onsiri Pitisuttithum, Katherine Copeland, Chatkamol Pheerapanyawaranun, Laddawan Jansarikit, Suvimol Niyomnaitham, Kulkanya Chokephaibulkit

Connect to this object online.

Comparison of immunogenicity and reactogenicity of inactivated SARS-CoV-2 vaccine (CoronaVac) in previously SARS-CoV-2 infected and uninfected health care workers by Ahmet Soysal, Erdem Gönüllü, Nalan Karabayır, Servet Alan, Serkan Atıcı, İsmail Yıldız, Havva Engin, Mahmut Çivilibal, Metin Karaböcüoğlu

Connect to this object online.

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: a randomized, double-blind, controlled phase III clinical trial in children aged 6-35 months in China by Yuemei Hu, Ming Shao, Yuansheng Hu, Qi Liang, Ningning Jia, Kai Chu, Li Xu, Jing Li, Changgui Li, Fengcai Zhu

Connect to this object online.

Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018-2019 season by Yuting Liao, Yan Jin, Hangjie Zhang, Juan Yang, Jian Fu, Huakun Lv

Connect to this object online.

A randomized Phase I/II study to evaluate safety and reactogenicity of a heat-stable rotavirus vaccine in healthy adults followed by evaluation of the safety, reactogenicity, and immunogenicity in infants by Vibhu Kanchan, Khalequ Zaman, Asma Binte Aziz, Sheikh Farzana Zaman, Farzana Zaman, Warda Haque, Mahbuba Khanam, Mohammad Mahbubul Karim, Sachin Kale, Syed Khalid Ali, Michelle G. Goveia, Susan S. Kaplan, Davinder Gill, Wasif Ali Khan, Mohammad Yunus, Ajitpal Singh, John D. Clemens

Connect to this object online.

Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers by Lorenz von Seidlein, Borimas Hanboonkunupakarn, Podjanee Jittamala, Pongphaya Pongsuwan, Kesinee Chotivanich, Joel Tarning, Richard M. Hoglund, Markus Winterberg, Mavuto Mukaka, Pimnara Peerawaranun, Pasathorn Sirithiranont, Zoe Doran, Christian F. Ockenhouse, Karen Ivinson, Cynthia Lee, Ashley J. Birkett, David C. Kaslow, Pratap Singhasivanon, Nicholas P.J. Day, Arjen M. Dondorp, Nicholas J. White, Sasithon Pukrittayakamee

Connect to this object online.

Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD) by Ozan S. Kumru, Sakshi Bajoria, Kawaljit Kaur, John M. Hickey, Greta Van Slyke, Jennifer Doering, Katherine Berman, Charles Richardson, Hans Lien, Harry Kleanthous, Nicholas J. Mantis, Sangeeta B. Joshi, David B. Volkin

Connect to this object online.

Immunogenicity consistency and safety with different production scales of recombinant adenovirus type-5 vectored COVID-19 vaccine in healthy adults: a randomized, double-blinded, immunobridging trial by Yan-Fei Wu, Ming-Wei Wei, Rui-Jie Wang, Xi-Ling Guo, Hong-Xing Pan, Ya-Chun Gao, Xiao-Long Li, Xue Wang, Xiao-Min Ma, Peng Wan, Li Zhou, Ya-Wen Zhu, Jing-Xin Li, Feng-Cai Zhu

Connect to this object online.

An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice by Callie E. Bounds, Frances E. Terry, Leonard Moise, Drew Hannaman, William D. Martin, Anne S. De Groot, John J. Suschak, Lesley C. Dupuy, Connie S. Schmaljohn

Connect to this object online.

Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvants by Sakshi Bajoria, Kawaljit Kaur, Ozan S. Kumru, Greta Van Slyke, Jennifer Doering, Hayley Novak, Sergio A. Rodriguez Aponte, Neil C. Dalvie, Christopher A. Naranjo, Ryan S. Johnston, Judith Maxwell Silverman, Harry Kleanthous, J. Christopher Love, Nicholas J. Mantis, Sangeeta B. Joshi, David B. Volkin

Connect to this object online.

Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial by Sanie Sesay, Jerzy Brzostek, Ingo Meyer, Yves Donazzolo, Geert Leroux-Roels, Régine Rouzier, Béatrice Astruc, Henryk Szymanski, Nicole Toursarkissian, Corinne Vandermeulen, Edyta Kowalska, Pierre Van Damme, Camille Salamand, Stephanie Pepin

Connect to this object online.

Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trial by Jianmin Chen, Feng Jiang, Chenyan Zhao, Jing Chai, Lanshu Li, Qinghu Guan, Xiaoyu Li, Feiyu Wang, Ansheng Li, Hongxia Gao, Minghui Wang, Liandi Fu, Fei Nie, Weijun Ling, Haobin Deng, Lei Zhou

Connect to this object online.

A simulated, randomized study on the safety and immunogenicity of three consecutive commercial-scale batches of the CTN-1V strain human rabies vaccine to verify the inter-batch consistency by Lei Zhou, Jingjing Liu, Jia Li, Xuecheng Liu, Jingwu Zhang, Fei Nie, Jianmin Chen, Jing Chai, Jinchao Lv, Minghui Wang, Jiajie Yu, Wenjie Wu, Yuhua Li, Yuhui Zhang

Connect to this object online.

Immunogenicity and safety of an inactivated COVID-19 vaccine (CoronaVac®) co-administered with an inactivated enterovirus type 71 vaccine (Inlive®): A phase 4, randomized, controlled trial by Yajun Shu, Zhuoqun Sun, Fan Gao, Zhuhang Huang, Xing Meng, Shaomin Chen, Qun Shu, Lianhao Wang, Hengming Zhang, Zhifang Ying, Jikai Zhang

Connect to this object online.